Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fibrotech Therapeutics Pty. Ltd.

Division of Takeda Pharmaceutical Co. Ltd.

Latest From Fibrotech Therapeutics Pty. Ltd.

Major New VC Fund To Support Australian Biotech

A leading Australian venture capital firm has raised the largest ever amount for a private investment fund in the life sciences sector in the country, which will support both early- and mid-stage biotech and device research.

BioPharmaceutical Medical Device

Deal Watch: Likely Break-up Of AbbVie/Shire Merger Shuffles Planning At Both Companies

J&J Innovation Center facilitates a lung cancer immunotherapy collaboration between Aduro and Janssen. Pentamer turns to crowdfunding to finance its work on an Ebola vaccine, and a host of other transactions from a frantic deal-making week.

BioPharmaceutical Deals

Deals Shaping The Medical Industry, June 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced April through May 2014.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Metabolic Disorders
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Takeda Pharmaceutical Co. Ltd.
  • Senior Management
  • Darren Kelly, CEO
  • Contact Info
  • Fibrotech Therapeutics Pty. Ltd.
    Phone: 3 9288 2546
    278 Collins St., Level 9
    Melbourne, 3000